Urothelial Cancer: Leveraging Circulating Tumor DNA To Avoid Unnecessary Bladder-directed and Systemic Therapies. Chatzkel J, Linscott J, Daniel Grass G, Li R, et al. Eur Urol Focus 2026;12:38-40.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chatzkel J, Linscott J, Daniel Grass G, Li R, et al. Urothelial Cancer: Leveraging Circulating Tumor DNA To Avoid Unnecessary Bladder-directed and Systemic Therapies. Eur Urol Focus 2026;12:38-40.
PMID: 40716995